Fasting conditions in clinical oncology trials and drug labelling Reply

被引：0
作者：
Lubberman, Floor J. E. [1 ]
Burger, David [1 ]
van Erp, Nielka P. [1 ]
机构：
[1] Radboud Univ Nijmegen, Dept Pharm, Med Ctr, NL-6500 HB Nijmegen, Netherlands
来源：
LANCET ONCOLOGY | 2017年 / 18卷 / 09期
关键词：
D O I：
10.1016/S1470-2045(17)30599-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E507 / E507
页数：1
相关论文
共 50 条
[41]   Phase 0 clinical trials in oncology: a paradigm shift for early drug development? [J].
Takimoto, Chris H. .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (04) :703-709
[42]   Phase zero clinical trials in oncology: a new paradigm for early drug development? [J].
Takimoto, C. H. .
EJC SUPPLEMENTS, 2006, 4 (12) :8-8
[43]   Phase 0 clinical trials in oncology: a paradigm shift for early drug development? [J].
Chris H. Takimoto .
Cancer Chemotherapy and Pharmacology, 2009, 63 :703-709
[44]   ONCOLOGY NURSE PRACTITIONERS AS PRINCIPAL INVESTIGATORS IN EARLY DRUG DEVELOPMENT CLINICAL TRIALS [J].
Jameson, Gayle ;
Pelusi, Jody ;
Rice, David ;
Sharrah, Karen ;
Burns, Kathleen ;
Von Hoff, Daniel .
ONCOLOGY NURSING FORUM, 2019, 46 (02)
[45]   Statistical Power for Clinical Trials of Proactive Therapeutic Drug Monitoring Reply [J].
D'haens, Geert R. ;
Sandborn, William J. .
GASTROENTEROLOGY, 2023, 164 (01) :166-168
[46]   New approach to clinical trials and drug registration - Author's reply [J].
Jones, TC .
BRITISH MEDICAL JOURNAL, 2001, 323 (7308) :341-341
[47]   BETTER DRUG TRIALS - REPLY [J].
CHERVINSKY, P .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1995, 96 (04) :568-568
[48]   ONCOLOGY DRUG DISCOVERY AND CLINICAL-TRIAL TESTING - WHOS LISTENING - REPLY [J].
SEITZ, DE .
CANCER INVESTIGATION, 1994, 12 (01) :107-108
[49]   MANUAL OF CLINICAL ONCOLOGY - REPLY [J].
LOVE, R .
ANNALS OF ONCOLOGY, 1991, 2 (07) :523-523
[50]   Clinical equipoise and randomised clinical trials in oncology [J].
Ferte, C. ;
Hollebecque, A. ;
Salleron, J. ;
Penel, N. .
BULLETIN DU CANCER, 2009, 96 (06) :727-731
12345